3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
41
Glioma
22
Brain Neoplasms
14
Astrocytoma
11
Neuroblastoma
10
Gliosarcoma
10
Neoplasms
8
Sarcoma, Ewing
7
Rhabdomyosarcoma
6
Sarcoma
5
Recurrence
5
Oligodendroglioma
5
Medulloblastoma
4
Small Cell Lung Carcinoma
3
Neoplasm Metastasis
3
Diffuse Intrinsic Pontine Glioma
3
Wilms Tumor
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Melanoma
2
Lymphoma, Follicular
2
Hepatoblastoma
2
Central Nervous System Neoplasms
2
Spinal Cord Neoplasms
1
Somatostatinoma
1
Rhabdoid Tumor
1
Refractory Solid Tumors
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Interventions
Radiotherapy, Conformal
2
Radiotherapy
2
Paclitaxel
2
Nivolumab
2
Carboplatin
2
veliparib
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Taxes
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Platinum
1
Metformin
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Immunoglobulin G
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Docetaxel
1
Disulfides
1
Cisplatin
1
CTLA-4 Antigen
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Bronchiolo-Alveolar
×
Temozolomide
×
90 days
×
Clear all
No trials found.